IP Library Granted Patent US 46,639
Granted Patent E1
US 46,639 · App. 14/333,454 · Granted Dec 19, 2017

4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same

Inventors: Alexander L. Ruchelman (Cream Ridge, NJ); George W. Muller (Rancho Santa Fe, CA); Hon-Wah Man (Princeton, NJ); Roger Shen-Chu Chen (Edison, NJ)
Assignee: Celgene Corporation
C07D401/04A61K31/454A61K31/4709A61K38/00A61K39/0011C07D401/14C07D405/14C07D409/14A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 46,639
App. No.
14/333,454
Granted
Dec 19, 2017
Kind
E1
Abstract

Provided are 4′-O substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Claims (40)

1. A compound of formula:

or a pharmaceutically acceptable salt or stereoisomer thereof,

wherein:

Y is CH 2 or C═O;

R 5 is aryl, optionally substituted with one, two or three groups selected from alkyl, halo, alkoxy, carboxy, alkylaminocarbonyl, alkoxycarbonyl, nitro, amine, nitrile, haloalkyl, hydroxy, alkylaminocarboxy, and alkylsulfonyl; and

n 1 is 0-5 1-5.

2. The compound of claim 1 , wherein Y is CH 2 .

3. The compound of claim 1 , wherein Y is C═O.

4. The compound of claim 1 , wherein the aryl is phenyl.

5. The compound of claim 1 , wherein the aryl is naphthyl.

6. The compound of claim 4 , wherein the phenyl is substituted with halo.

7. The compound of claim 5 , wherein the naphthyl is substituted with halo.

8. The compound of claim 4 , wherein the phenyl is substituted with alkyl or alkoxy.

9. The compound of claim 5 , wherein the naphthyl is substituted with alkyl or alkoxy.

10. The compound of claim 1 , which is:

11. The compound of claim 1 , which is:

12. A compound of formula:

or a pharmaceutically acceptable salt or stereoisomer thereof,

wherein:

Y is CH 2 or C═O;

R 5 is aryl, optionally substituted with one, two or three groups selected from alkyl, halo, alkoxy, carboxy, alkylaminocarbonyl, alkoxycarbonyl, nitro, amine, nitrile, haloalkyl, hydroxy, alkylaminocarboxy, and alkylsulfonyl; and

n 1 is 0.

13. The compound of claim 12, wherein Y is CH 2 .

14. The compound of claim 12, wherein Y is C═O.

15. The compound of claim 12, wherein the aryl is phenyl.

16. The compound of claim 12, wherein the aryl is naphthyl.

17. The compound of claim 15, wherein the phenyl is substituted with halo.

18. The compound of claim 16, wherein the naphthyl is substituted with halo.

19. The compound of claim 15, wherein the phenyl is substituted with alkyl or alkoxy.

20. The compound of claim 16, wherein the naphthyl is substituted with alkyl or alkoxy.

21. The compound of claim 12, which is:

22. A compound of formula:

or a pharmaceutically acceptable salt or stereoisomer thereof,

wherein:

Y is CH 2 or C═O;

R 5 is naphthyl; and

n 1 is 1-5.

23. The compound of claim 22, wherein Y is CH 2 .

24. The compound of claim 22, wherein Y is C═O.

25. The compound of claim 22, which is:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2017
From: RUCHELMAN, ALEXANDER L.; MULLER, GEORGE W.; MAN, HON-WAH
To: CELGENE CORPORATION
Reel/Frame 044425/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2017
From: CHEN, ROGER SHEN-CHU
To: CELGENE CORPORATION
Reel/Frame 044425/0995 →
Continuity (3)
Reissue 13410216 · Mar 1, 2012
Continuation 12077715 · Mar 19, 2008
Provisional Application 60919323 · Mar 20, 2007